Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04116632 · ClinicalTrials.gov registry record · Phase 1
A Multiple Dose Study to Assess the Safety and Tolerability of BMS-963272 in Obese But Otherwise Healthy Adults
A Phase 1 study, sponsored by Bristol-Myers Squibb.
- Completed
- Registry status
- Phase 1
- Development phase
- 36
- Enrollment target
NCT04116632 is a Phase 1 study that has completed, run by Bristol-Myers Squibb. The registered enrollment target is 36 participants.
The verdict
NCT04116632, a Phase 1 study, has completed, sponsored by Bristol-Myers Squibb.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 36 participants
- Enrollment target
Study Summary
This study will assess the safety and tolerability of multiple doses of BMS-963272 in obese but otherwise healthy participants.
Interventions
- DRUG Placebo
- DRUG BMS-963272
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2019-09-30 |
| Est. Completion | 2020-02-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04116632
The ClinicalTrials.gov registry entry for NCT04116632 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bristol-Myers Squibb, which has 1,025 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT04116632 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04116632 about?
NCT04116632 is a clinical study titled "A Multiple Dose Study to Assess the Safety and Tolerability of BMS-963272 in Obese But Otherwise Healthy Adults". This study will assess the safety and tolerability of multiple doses of BMS-963272 in obese but otherwise healthy participants.
What is the current status of trial NCT04116632?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 36 participants. The study started on 2019-09-30. Estimated completion is 2020-02-10.
What interventions are being tested in trial NCT04116632?
The interventions under investigation include: Placebo (DRUG), BMS-963272 (DRUG).
Who is sponsoring clinical trial NCT04116632?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.